Office Management of Ozurdex Implant Dislocation into the Anterior Chamber

PURPOSE To describe a novel in office procedure which permits the repositioning of an Ozurdex implant from the anterior chamber back into the vitreous cavity. METHODS Description of an office technique for Ozurdex repositioning using a 30-gauge needle. RESULTS In both cases the Ozurdex implant was successfully returned to the vitreous cavity. In case 1 the patient's visual acuities one and two weeks after this were 20/70 and 20/40, respectively, and had no further complications. In case 2 the patient returned one week later, with the implant remaining posterior and a visual acuity of 20/40. CONCLUSION The success of this novel technique in these cases demonstrates the potential to avoid a surgical procedure in the event of Ozurdex implant migration to the AC, while at the same time allowing the Ozurdex implant to remain effective in the eye.